Brief: Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020
15/03/2021 20:42
March 15 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS AND FULL-YEAR ENDED DECEMBER 31, 2020
* Q4 GAAP LOSS PER SHARE $0.13
* Q4 REVENUE $95.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$88.9
MILLION
* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.16
* Q4 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNXbn2tmN
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray